经皮动脉导管药盒系统药物灌注治疗并发菌血症的原因分析  

Analysis of bacteremia of patients with malignant tumors after PCS treatment

作　　者：王东盛[1] 陆英[1] 王成纲[1] 刘明[1] 刘海洋[1] 

机构地区：[1]北京煤炭总医院介入科,北京100028

出　　处：《中国医药导报》2011年第12期185-185,188,共2页China Medical Herald

摘　　要：目的:探讨患者植入动脉导管药盒系统(implantable reservoir port and catheter connecting system,PCS)后行药物灌注治疗,发生菌血症的原因。方法:对163例行动脉导管药盒系统植入后进行药物灌注治疗的中晚期肿瘤患者进行多因素回顾分析、总结。结果:163例中晚期肿瘤患者行动脉导管药盒系统植入后进行药物灌注治疗,有14例发生菌血症。菌血症的发生与合并肝硬化、糖尿病、药盒皮囊积血、穿刺针留置时间等因素有关。结论:多因素分析可减少经皮动脉导管药盒系统药物灌注治疗的并发症。Objective：To study the cause of bacteremia of patients who were treated by PCS. Methods： Multivariate analysis of data of 163 patients with advanced turnout who were treated by PCS. Results： Of 163 patients, 14 patients had bacteremia after PCS treatment. There was a closely correlation between bacteremia and cirrhosis and diabetes mellitus and extravasated blood and the detaining time of arterial cannula. Conclusion： Multivariate analysis of clinical data can reduce complications of patients who were treated by PCS.

关 键 词：导管药盒系统 菌血症 并发症 

分 类 号：R730.5[医药卫生—肿瘤]